Cullen Frost Bankers Inc. Sells 2,102 Shares of Danaher Co. (NYSE:DHR)

Cullen Frost Bankers Inc. trimmed its position in Danaher Co. (NYSE:DHR) by 1.4% in the fourth quarter, Holdings Channel.com reports. The firm owned 152,018 shares of the conglomerate’s stock after selling 2,102 shares during the period. Cullen Frost Bankers Inc.’s holdings in Danaher were worth $35,168,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in DHR. BKM Wealth Management LLC bought a new position in Danaher in the fourth quarter valued at approximately $27,000. Wetzel Investment Advisors Inc. acquired a new stake in shares of Danaher in the 4th quarter valued at approximately $29,000. OFI Invest Asset Management bought a new position in Danaher during the 3rd quarter worth approximately $30,000. Rakuten Securities Inc. acquired a new position in Danaher during the fourth quarter valued at approximately $36,000. Finally, Financial Connections Group Inc. bought a new stake in Danaher in the fourth quarter valued at approximately $41,000. 79.05% of the stock is owned by institutional investors.

Insider Buying and Selling

In other Danaher news, Director Walter G. Lohr sold 3,289 shares of the company’s stock in a transaction on Thursday, February 15th. The stock was sold at an average price of $251.15, for a total value of $826,032.35. Following the transaction, the director now directly owns 14,129 shares of the company’s stock, valued at approximately $3,548,498.35. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. In other news, Director Walter G. Lohr sold 3,289 shares of the firm’s stock in a transaction that occurred on Thursday, February 15th. The shares were sold at an average price of $251.15, for a total transaction of $826,032.35. Following the transaction, the director now directly owns 14,129 shares of the company’s stock, valued at $3,548,498.35. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CEO Rainer Blair sold 47,175 shares of the business’s stock in a transaction that occurred on Wednesday, April 24th. The shares were sold at an average price of $249.22, for a total value of $11,756,953.50. Following the completion of the sale, the chief executive officer now owns 115,995 shares of the company’s stock, valued at $28,908,273.90. The disclosure for this sale can be found here. In the last ninety days, insiders sold 103,984 shares of company stock valued at $25,997,094. Insiders own 10.90% of the company’s stock.

Danaher Stock Performance

NYSE DHR traded up $1.45 during trading on Tuesday, reaching $248.85. 1,683,401 shares of the company’s stock were exchanged, compared to its average volume of 2,744,101. Danaher Co. has a fifty-two week low of $182.09 and a fifty-two week high of $259.00. The stock has a market capitalization of $184.32 billion, a P/E ratio of 42.18, a PEG ratio of 3.82 and a beta of 0.83. The business has a 50 day moving average price of $248.27 and a 200-day moving average price of $233.19. The company has a debt-to-equity ratio of 0.31, a current ratio of 1.85 and a quick ratio of 1.51.

Danaher (NYSE:DHR) last announced its quarterly earnings results on Tuesday, April 23rd. The conglomerate reported $1.92 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.72 by $0.20. Danaher had a return on equity of 11.43% and a net margin of 16.78%. The business had revenue of $5.80 billion during the quarter, compared to the consensus estimate of $5.62 billion. During the same quarter last year, the firm posted $2.36 EPS. The company’s quarterly revenue was down 2.6% on a year-over-year basis. Sell-side analysts forecast that Danaher Co. will post 7.63 earnings per share for the current fiscal year.

Danaher Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, July 26th. Shareholders of record on Friday, June 28th will be given a dividend of $0.27 per share. This represents a $1.08 annualized dividend and a yield of 0.43%. Danaher’s dividend payout ratio (DPR) is presently 18.31%.

Analyst Ratings Changes

Several analysts recently commented on DHR shares. TD Cowen raised their price objective on Danaher from $280.00 to $290.00 and gave the stock a “buy” rating in a research note on Wednesday, April 24th. Bank of America upped their price target on shares of Danaher from $258.00 to $270.00 and gave the company a “neutral” rating in a report on Wednesday, April 24th. StockNews.com cut Danaher from a “buy” rating to a “hold” rating in a report on Wednesday, January 31st. Raymond James lifted their target price on Danaher from $240.00 to $270.00 and gave the company an “outperform” rating in a research report on Wednesday, January 31st. Finally, Robert W. Baird upped their price target on Danaher from $259.00 to $271.00 and gave the stock an “outperform” rating in a research report on Wednesday, April 24th. Six analysts have rated the stock with a hold rating and nine have issued a buy rating to the company. Based on data from MarketBeat, Danaher currently has a consensus rating of “Moderate Buy” and a consensus price target of $267.31.

About Danaher

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.